How GlaxoSmithKline Lost Nearly $10B in October Post author:Sam Post published:November 9, 2017 Post category:BioPharma Could GlaxoSmithKline’s industry-leading dividend be at risk? Source: BioSpace You Might Also Like Foundation Medicine, Inc. Announces Timing For First Quarter 2017 Financial Results And Conference Call April 19, 2017 The IDO Battle Gets Ugly October 24, 2017 4 Solid Biotechs to Load Up on This Month December 3, 2017
Foundation Medicine, Inc. Announces Timing For First Quarter 2017 Financial Results And Conference Call April 19, 2017
